Q2 2023 · 13F-HR
Caligan Partners LPholdings as filed
Filed 2023-08-14 · accession 0001727492-23-000009
$177.8M
Reported value
13
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 53635D202 | LQDA | LIQUIDIA CORP | $72.6M | 40.8% | 9,243,627 | Common | SOLE |
| 035255108 | ANIK | ANIKA THERAPEUTICS INC | $18.7M | 10.5% | 720,291 | Common | SOLE |
| 30161Q104 | EXEL | EXELIXIS INC | $17.4M | 9.79% | 910,730 | Common | SOLE |
| 34385P108 | LAB | STANDARD BIOTOOLS INC | $16.3M | 9.19% | 8,467,920 | Common | SOLE |
| 45845P108 | — | INTERCEPT PHARMACEUTICALS INC | $14.3M | 8.05% | 1,293,510 | Common | SOLE |
| 45845P958 | — | INTERCEPT PHARMACEUTICALS INC | $13.3M | 7.46% | 1,200,000 | PUT | SOLE |
| 30052C107 | EOLS | EVOLUS INC | $12.8M | 7.20% | 1,760,136 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $3.9M | 2.18% | 183,064 | Common | SOLE |
| 000899104 | ADMA | ADMA BIOLOGICS INC | $3.1M | 1.76% | 847,513 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $2.7M | 1.52% | 310,298 | Common | SOLE |
| 016259202 | — | ALIMERA SCIENCES INC | $1.4M | 0.79% | 478,777 | Common | SOLE |
| 75629F109 | RAH | SOCIETAL CDMO INC | $1.2M | 0.67% | 1,077,268 | Common | SOLE |
| 00847X104 | AGIO | AGIOS PHARMACEUTICALS INC | $136,871 | 0.08% | 4,833 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.